Search clinical trials for: Tocotrienol 300 mg x 3 daily
Total 296 results
-
Vejle HospitalTerminated
-
Basilea PharmaceuticaCompletedUrothelial CarcinomaUnited Kingdom, Korea, Republic of, Italy, Canada, France, Spain, Germany, United States, Hungary, Australia, Poland, Switzerland, Czechia, Austria
-
MedImmune LLCCompletedHealthy VolunteerUnited Kingdom
-
Oslo University HospitalTakeda Nycomed; Sykehuset Asker og BaerumCompleted
-
AstraZenecaCompleted
-
Johnson & Johnson Pharmaceutical Research & Development...TerminatedAtopic DermatitisUnited States
-
Boehringer IngelheimCompletedPsoriasisUnited States, Canada, Germany
-
Tibotec Pharmaceuticals, IrelandCompletedHuman Immunodeficiency Virus Type 1Germany
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
University of Alabama at BirminghamNovartisTerminatedHypertension | Diabetes | Pre-hypertensionUnited States
-
Maruho Co., Ltd.Completed
-
Vejle HospitalCompleted
-
Chong Kun Dang PharmaceuticalCompletedDyslipidemiasKorea, Republic of
-
Ixchelsis LimitedCompleted
-
NovartisCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom, Netherlands
-
Eli Lilly and CompanyCompletedGlioblastoma MultiformeGermany
-
University of California, San FranciscoRecruiting
-
Medical University of South CarolinaCompletedFibromyalgiaUnited States
-
Malaysia Palm Oil BoardUniversiti Putra MalaysiaUnknownInflammation | Cardiovascular Risk FactorMalaysia
-
Celularity IncorporatedCompletedDiabetic Foot | Peripheral Arterial DiseaseUnited States
-
Marius HenriksenTerminatedCorona Virus DiseaseDenmark
-
Global Alliance for TB Drug DevelopmentCompletedTuberculosis | Tuberculosis, PulmonaryUnited States
-
Centre Hospitalier Universitaire, AmiensMerck Serono International SACompletedRenal Disorder Associated With Type II Diabetes MellitusFrance
-
Icahn School of Medicine at Mount SinaiLEO PharmaCompletedActinic KeratosisUnited States
-
Bial - Portela C S.A.CompletedParkinson's DiseaseSwitzerland
-
CTI BioPharmaPPDRecruiting
-
MerLion Pharmaceuticals GmbHCompletedSafety and TolerabilityUnited States
-
CymaBay Therapeutics, Inc.CompletedHomozygous Familial HypercholesterolemiaCanada, France, Netherlands, Norway
-
Bristol-Myers SquibbCompleted
-
Evandro Chagas Institute of Clinical ResearchNot yet recruitingChronic Chagas DiseaseBrazil
-
Human Genome Sciences Inc.GlaxoSmithKlineCompleted
-
ViiV HealthcareGlaxoSmithKlineTerminatedInfection, Human Immunodeficiency VirusUnited States, Canada, Italy, Belgium, Romania
-
Virginia Commonwealth UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart FailureUnited States
-
Alexza Pharmaceuticals, Inc.Atlanta Center for Medical ResearchCompleted
-
University of WashingtonProcter and GambleCompleted
-
University of MichiganFood and Drug Administration (FDA)CompletedLocal Drug Concentration in Gastrointestinal TractUnited States
-
AstraZenecaQuotient SciencesCompletedCancerUnited Kingdom
-
Bial - Portela C S.A.Completed
-
Flame BiosciencesWithdrawnGastric Cancer | Solid Tumor | Pancreas Cancer
-
Eisai LimitedTerminatedEpilepsyUnited Kingdom, Germany, Hungary, Switzerland, Italy, Netherlands, Poland
-
VA Office of Research and DevelopmentCompletedGeneralized Anxiety DisorderUnited States
-
Egyptian Liver HospitalWadi El Nil HospitalCompleted
-
Janssen R&D IrelandCompletedHIV Infections | Acquired Immunodeficiency SyndromeUnited States, France, Argentina, South Africa, Thailand
-
Aziende Chimiche Riunite Angelini Francesco S.p.AHippocrates ResearchRecruiting
-
Ardea Biosciences, Inc.Quotient ClinicalCompleted
-
Lady Davis InstituteRecruitingAcneiform Eruptions | Cancer, Treatment-RelatedCanada
-
PfizerHalozyme TherapeuticsTerminatedHealthy | HypercholesterolemiaBelgium